EUVIMEDEUVIMED entdecken
Open Access

The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism

David B Finlay, Warwick Mackie, Hunter D J Webb, Lucy R Thomsen, Mhairi Nimick, Rhonda J Rosengren, Julie A Marusich, Michelle Glass, Jenny L Wiley

Pharmacology Biochemistry and Behavior · 2023

DOI: 10.1016/j.pbb.2023.173530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2023. Verfasst von David B Finlay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: david.finlay@o…. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Cannabinoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cannabinoid Receptor AgonistsCannabinoidsRatsMiceHumansAnimalsPiperazineIndazolesReceptor, Cannabinoid, CB1Valine

Stichwörter der Autor:innen

Cardiovascular effectsParty pillsPlethysmographyPolypharmacologySynthetic cannabinoid receptor agonistsTelemetry

Substanzen

Cannabinoid Receptor AgonistsPiperazineCannabinoidsIndazolesReceptor, Cannabinoid, CB1methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoateValine

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: david.finlay@otago.ac.nz.
  • Department of Pharmacology & Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • RTI International, Research Triangle Park, NC, USA.

Förderung

  • NIDA NIH HHS
  • National Institutes of Health
  • National Institute on Drug Abuse
  • Health Research Council of New Zealand

Zitieren

APA

Finlay, D. B., Mackie, W., Webb, H. D. J., Thomsen, L. R., Nimick, M., Rosengren, R. J., Marusich, J. A., Glass, M., & Wiley, J. L. (2023). The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2023.173530

Vancouver

Finlay DB, Mackie W, Webb HDJ, Thomsen LR, Nimick M, Rosengren RJ, et al. The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Pharmacology Biochemistry and Behavior. 2023. doi:10.1016/j.pbb.2023.173530

BibTeX
@article{Finlay2023,
  author = {Finlay, David B and Mackie, Warwick and Webb, Hunter D J and Thomsen, Lucy R and Nimick, Mhairi and Rosengren, Rhonda J and Marusich, Julie A and Glass, Michelle and Wiley, Jenny L},
  title = {The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2023},
  doi = {10.1016/j.pbb.2023.173530}
}
Kostenlos starten →